BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walter F, Böckle D, Schmidt-Hegemann NS, Köpple R, Gerum S, Boeck S, Angele M, Belka C, Roeder F. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis. Radiat Oncol 2018;13:93. [PMID: 29769143 DOI: 10.1186/s13014-018-1044-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi Z, Zhu X, Ke S, Qiu H, Cai G, Zhangcai Y, Chen Y. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses. Radiother Oncol 2021;164:236-44. [PMID: 34627936 DOI: 10.1016/j.radonc.2021.09.033] [Reference Citation Analysis]
2 Rahimy E, Koong A, Toesca D, White MN, Panjwani N, Fisher G, Chang D, Pollom E. Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review. Adv Radiat Oncol 2020;5:1188-96. [PMID: 33305080 DOI: 10.1016/j.adro.2020.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Mori M, Doki Y. Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review. Ann Gastroenterol Surg. 2019;3:169-180. [PMID: 30923786 DOI: 10.1002/ags3.12222] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
4 Hamamoto Y, Murakami K, Kato K, Kitagawa Y. Management of elderly patients with esophageal squamous cell cancer. Jpn J Clin Oncol 2022:hyac067. [PMID: 35511482 DOI: 10.1093/jjco/hyac067] [Reference Citation Analysis]
5 Kawamoto T, Shikama N, Mine S, Tsurumaru M, Sasai K. Clinical impact of baseline renal function on the safety of radiotherapy with concurrent docetaxel for esophageal cancer in elderly patients. Esophagus 2020;17:425-32. [PMID: 32170545 DOI: 10.1007/s10388-020-00731-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Dohm A, Diaz R, Nanda RH. The Role of Radiation Therapy in the Older Patient. Curr Oncol Rep 2021;23:11. [PMID: 33387104 DOI: 10.1007/s11912-020-01000-y] [Reference Citation Analysis]
7 Jia X, Huang C, Hu Y, Wu Q, Liu F, Nie W, Chen H, Li X, Dong Z, Liu K. Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 2021;40:105. [PMID: 33731185 DOI: 10.1186/s13046-021-01903-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rogowski P, Trapp C, von Bestenbostel R, Eze C, Ganswindt U, Li M, Unterrainer M, Zacherl MJ, Ilhan H, Beyer L, Kretschmer A, Bartenstein P, Stief C, Belka C, Schmidt-Hegemann NS. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy. Eur J Nucl Med Mol Imaging 2021. [PMID: 34628521 DOI: 10.1007/s00259-021-05557-z] [Reference Citation Analysis]
9 Walter F, Jell C, Zollner B, Andrae C, Gerum S, Ilhan H, Belka C, Niyazi M, Roeder F. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful? Strahlenther Onkol 2021;197:780-90. [PMID: 33104815 DOI: 10.1007/s00066-020-01701-0] [Reference Citation Analysis]
10 Kawamoto T, Shikama N, Oshima M, Kosugi Y, Tsurumaru M, Sasai K. Safety of radiotherapy with concurrent docetaxel in older patients with esophageal cancer. J Geriatr Oncol 2020;11:675-9. [PMID: 31471169 DOI: 10.1016/j.jgo.2019.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Deantonio L, Cima S, Leva S, Richetti A, Valli M. Hypofractionated volumetric modulated arc therapy (VMAT) for fragile patients with oesophageal cancer. Clin Transl Oncol 2020;22:1532-8. [PMID: 31970685 DOI: 10.1007/s12094-020-02293-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ji Y, Du X, Zhu W, Yang Y, Ma J, Zhang L, Li J, Tao H, Xia J, Yang H, Huang J, Bao Y, Du D, Liu D, Wang X, Li C, Yang X, Zeng M, Liu Z, Zheng W, Pu J, Chen J, Hu W, Li P, Wang J, Xu Y, Zheng X, Chen J, Wang W, Tao G, Cai J, Zhao J, Zhu J, Jiang M, Yan Y, Xu G, Bu S, Song B, Xie K, Huang S, Zheng Y, Sheng L, Lai X, Chen Y, Cheng L, Hu X, Ji W, Fang M, Kong Y, Yu X, Li H, Li R, Shi L, Shen W, Zhu C, Lv J, Huang R, He H, Chen M. Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial. JAMA Oncol 2021. [PMID: 34351356 DOI: 10.1001/jamaoncol.2021.2705] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lin JB, Hung LC, Cheng CY, Chien YA, Lee CH, Huang CC, Chou TW, Ko MH, Lai YC, Liu MT, Chang TH, Lee J, Chen YJ. Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy. Radiat Oncol 2019;14:85. [PMID: 31126307 DOI: 10.1186/s13014-019-1283-3] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cooper L, Dezube AR, De León LE, Kucukak S, Mazzola E, Dumontier C, Mamon H, Enzinger P, Jaklitsch MT, Frain LN, Wee JO. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer. Eur J Surg Oncol 2021:S0748-7983(21)00418-2. [PMID: 33895020 DOI: 10.1016/j.ejso.2021.04.013] [Reference Citation Analysis]
15 van Holstein Y, Trompet S, van Deudekom FJ, van Munster B, de Glas NA, van den Bos F, Uit den Boogaard A, van der Elst MJT, van der Kaaij MAE, Neelis KJ, Langers AMJ, Slingerland M, Portielje JEA, Mooijaart SP. Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer. Acta Oncol 2022;61:459-67. [PMID: 35193449 DOI: 10.1080/0284186X.2022.2036366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]